Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in
Pre-market
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverDXR
NasdaqCMUSD

Daxor Corporation

$0012345678900123456789.0012345678900123456789-2.4%
52w low $8.56$14.76 52w high
Market data · last updated 1d ago
Market data
52w range
$8.56 - $14.76
Sector
Unknown
Run the 10-point checklist before you buy How these numbers are made

About Daxor Corporation

Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation operates as a subsidiary of Estate Of Joseph Feldschuh.

Valuation

Overall Rating
0
Not rated
Not rated
Moat Score0
Fair value estimate
Not covered by our valuation model yet.

Moat, fair value and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
P/E Ratio
N/A
Dividend Yield
0.00%
Revenue Growth
0.0%
Profit Margin
0.0%
ROE
0.0%
Debt / Equity
0.00
Beta
0.00

Statistics

Similar Stocks · Unknown

Latest News · DXR